Crescent Biopharma, Inc. (CBIO)
$16.97-1.05%Close
BUYRECOVERY · day 15
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $468M
- Avg volume
- 321.3K
- Beta
- 1.22
- P/E (TTM)
- -2.24
- Short % float
- 16.25%
- Days to cover
- 8.9
- SI change
- -7.4%
- 1W
- -2.92%
- 1M
- +4.11%
- 3M
- -18.18%
- YTD
- +53.16%
- vs SPY 1W
- -1.73%
- vs SPY 1M
- +0.79%
- vs SPY 3M
- -20.57%
- vs SPY YTD
- +41.40%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CVSELLCapsoVision, Inc.CRISISQ 39$5.83-3.16%
- ENTABUYEnanta Pharmaceuticals, Inc.RECOVERYQ 13$14.10+4.68%
- COSMSELLCosmos Health Inc.RECOVERYQ -3$0.21-4.55%
- ENSCBUYEnsysce Biosciences, Inc.CRISISQ -25$0.36-2.70%
- JANXBUYJanux Therapeutics, Inc.RECOVERYQ 12$18.60+6.96%
- NRXSSELLNeurAxis, Inc.BEARQ 15$6.07-1.30%
- BOLTSELLBolt Biotherapeutics, Inc.RECOVERYQ -39$3.74+1.91%
- HCTISELLHealthcare Triangle, Inc.CRISISQ -27$0.84-4.55%
- ADGMBUYAdagio Medical Holdings, Inc.CRISISQ -22$0.59-9.23%
- BBIOSELLBridgeBio Pharma, Inc.RECOVERYQ 20$81.07-0.53%
- CDIOBUYCardio Diagnostics Holdings, Inc.CRISISQ -18$1.93-4.93%
- CVRXSELLCVRx, Inc.CRISISQ -21$3.15+10.92%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 7
- VALUE
- 12
- GROWTH
- 19
- GARP
- 4
- TYPE
- Value / Recovery (blended)
Composite of Value · Growth · GARP
ROIC-58.7%
REV YoY-
ROE-97.8%
EPS YoY-
ROA-89.2%
GROSS100
OP-1418
NET-1372
[VALUATION]
P/E TTM-2.24
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B3.17
P/FCF-
EV/EBITDA-2.82
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.88
ALTMAN Z-
CURR RATIO9.66
ND/EBITDA-
BETA1.22
